Current issue
Archive
About the journal
Editorial board
Abstracting and indexing
Subscription
Contact
Instructions for authors
Publication charge
Ethical standards and procedures
Editorial System
Submit your Manuscript
|
1/2019
vol. 100 abstract:
RESEARCH PAPERS
Synthesis and in vitro anticancer activity of N-alkyl phosphoramidate monoesters of 3’-azido-3’-deoxythymidine (AZT)
Ewa Czajkowska-Wojciechowska
1
,
Aleksandra Singh
1
,
Roksana Trznadel
1
,
Piotr Ruszkowski
2
,
Lech Celewicz
1
BioTechnologia vol. 100 (1) C pp. 81–88 C 2019
Online publish date: 2019/03/27
View
full text
Get citation
ENW EndNote
BIB JabRef, Mendeley
RIS Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
In this study, a series of novel N-alkyl phosphoramidate monoesters of 3’-azido-3’-deoxythymidine (AZT) were synthesized using two methods. The synthesized phosphoramidates 7a–e were evaluated for their cytotoxic activity in three human cancer cell lines (cervical cancer (HeLa), nasopharyngeal cancer (KB), and breast cancer (MCF-7)) and a normal dermal fibroblast cell line (HDF) using sulforhodamine B assay. Among the synthesized phosphoramidates, the highest cytotoxic activity was demonstrated by phosphoramidate 7d with the N-n-propyl substituent in all the examined cancer cell lines, and its activity was found to be about two fold higher than that of the parent nucleoside (AZT). Phosphoramidate 7d showed not only a high cytotoxic activity against cancer cell lines but also a low toxicity against normal fibroblast cells; its selectivity index was >3 for all the investigated cancer cell lines. A slightly lower cytotoxic activity was shown by phosphoramidates 7a, 7b, and 7e, whereas phosphoramidate 7c with the N-(2,2,2-trifluoroethyl) substituent exhibited the least cytotoxic activity in all the cell lines used.
keywords:
N-alkyl phosphoramidate monoesters of 3’-azido-3’-deoxythymidine, cytotoxic activity, human cancer cell lines – HeLa, KB, MCF-7, normal human cell line – HDF |